These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27139)

  • 1. Irreversible effects of serum proteins on beta-lactam antibiotics.
    O'Callaghan CH
    Antimicrob Agents Chemother; 1978 Apr; 13(4):628-33. PubMed ID: 27139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of pyridine-2-azo-p-dimethylaniline cephalosporin, a new diagnostic chromogenic reagent, and comparison with nitrocefin, cephacetrile, and other beta-lactam compounds.
    Jones RN; Wilson HW; Novick WJ
    J Clin Microbiol; 1982 Apr; 15(4):677-83. PubMed ID: 6978350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hydrogen ion and protein concentrations on the activity of beta-lactam antibiotics.
    Platt R; Rosner B
    Rev Infect Dis; 1984; 6 Suppl 4():S829-34. PubMed ID: 6522925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of lytic effect of beta lactams on Escherichia coli and other bacteria.
    Goodell EW; Lopez R; Tomasz A
    Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3293-7. PubMed ID: 9642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxylamine inactivation of cephalosporins: nucleophilic attack on beta-lactam structures.
    Uri JV
    Acta Microbiol Hung; 1984; 31(4):399-404. PubMed ID: 6443055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic basis for the action of new cephalosporin antibiotics effective against methicillin- and vancomycin-resistant Staphylococcus aureus.
    Fuda C; Hesek D; Lee M; Heilmayer W; Novak R; Vakulenko SB; Mobashery S
    J Biol Chem; 2006 Apr; 281(15):10035-41. PubMed ID: 16459335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insignificant β-lactamase activity of human serum albumin: no panic to nonmicrobial-based drug resistance.
    Rehman MT; Faheem M; Khan AU
    Lett Appl Microbiol; 2013 Oct; 57(4):325-9. PubMed ID: 23758063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the omega-loop in the activity, substrate specificity, and structure of class A beta-lactamase.
    Banerjee S; Pieper U; Kapadia G; Pannell LK; Herzberg O
    Biochemistry; 1998 Mar; 37(10):3286-96. PubMed ID: 9521648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific interaction between beta-lactams and soluble penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus: development of a chromogenic assay.
    Roychoudhury S; Kaiser RE; Brems DN; Yeh WK
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2075-9. PubMed ID: 8878584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural specificity requirements in the binding of beta lactam antibiotics to human serum albumin.
    Nerli B; Romanini D; Picó G
    Chem Biol Interact; 1997 May; 104(2-3):179-202. PubMed ID: 9212783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics.
    Wick WE; Preston DA
    Antimicrob Agents Chemother; 1972 Mar; 1(3):221-34. PubMed ID: 5045468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
    de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
    Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus.
    Sabath LD
    Ann Intern Med; 1982 Sep; 97(3):339-44. PubMed ID: 6981367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anion-exchange extraction of cephapirin, cefotaxime, and cefoxitin from serum for liquid chromatography.
    Fasching CE; Peterson LR
    Antimicrob Agents Chemother; 1982 Apr; 21(4):628-33. PubMed ID: 6282213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
    Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence of human serum albumin beta-lactamase activity.
    Nerli B; Picó G
    Biochem Mol Biol Int; 1994 Mar; 32(4):789-95. PubMed ID: 8038728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and properties of disodium tetraethyleneglycol-bis-(alpha-carboxybenzylpenicillin).
    Kim YT; Jung YJ; Kim YM
    Drug Dev Ind Pharm; 1999 Apr; 25(4):523-8. PubMed ID: 10194608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative stability of cephalosporins in aqueous solution: kinetics and mechanisms of degradation.
    Yamana T; Tsuji A
    J Pharm Sci; 1976 Nov; 65(11):1563-74. PubMed ID: 11330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascitic fluid cephalosporin concentrations: influence of protein binding and serum pharmacokinetics.
    Gerding DN; Peterson LR; Legler DC; Hall WH; Schierl EA
    Antimicrob Agents Chemother; 1978 Aug; 14(2):234-9. PubMed ID: 697350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological perfusion model for cephalosporin antibiotics I: Model selection based on blood drug concentrations.
    Greene DS; Quintiliani R; Nightingale CH
    J Pharm Sci; 1978 Feb; 67(2):191-6. PubMed ID: 621635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.